This study focuses on pancreatic cancer, specifically a type called adenocarcinoma (a cancer that starts in glandular cells). The aim is to see how a protein called convertases is expressed in cancer tissues and if it can help doctors predict patient outcomes better. If you join, doctors will collect samples from your tumor and blood during a biopsy or surgery. You'll be followed for two years to check your cancer status and overall health.
- Study Length: 2 years follow-up.
- Visits Needed: Biopsy or surgery day for sample collection.
- Risks: Standard risks associated with biopsy or surgery.
To participate, you need to be 18 or older with suspected or confirmed pancreatic cancer. You should not have undergone certain treatments recently or be unable to follow study procedures due to personal factors. This is a single-center, observational study, meaning no new treatments are given as part of this research. Your regular cancer care will continue as usual. Participation is voluntary, and you need to sign a consent form agreeing to join the study.